GILEAD SCIENCES, INC. Dividends Declared
GILEAD SCIENCES, INC. (GILD) reported Dividends Declared of $1.03 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:Dividends · last filed 2026-08-06
- GILEAD SCIENCES, INC. dividends for the quarter ending 2026-06-30 was $1.03B, a 3.41% increase year-over-year.
- GILEAD SCIENCES, INC. dividends for the quarter ending 2026-03-31 was $1.03B, a 3.09% increase year-over-year.
- GILEAD SCIENCES, INC. dividends for the quarter ending 2025-12-31 was $993.00M, a 1.74% increase year-over-year.
- GILEAD SCIENCES, INC. dividends for the quarter ending 2025-09-30 was $995.00M, a 1.84% increase year-over-year.
- GILEAD SCIENCES, INC. dividends for fiscal 2025 was $3.99B, a 1.99% increase from fiscal 2024.
- GILEAD SCIENCES, INC. dividends for fiscal 2024 was $3.91B, a 2.54% increase from fiscal 2023.
- GILEAD SCIENCES, INC. dividends for fiscal 2023 was $3.81B, a 2.39% increase from fiscal 2022.
- GILEAD SCIENCES, INC. dividends for fiscal 2022 was $3.73B, a 2.96% increase from fiscal 2021.
| Period end | Dividends 3 month | Dividends 6 month | Dividends 9 month | Dividends 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.03B 10-Q · filed 2026-08-06 | $2.07B 10-Q · filed 2026-08-06 | $3.06B derived: sum of 3 quarters · filed 2026-08-06 | $4.05B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.03B 10-Q · filed 2026-05-07 | $2.03B derived: sum of 2 quarters · filed 2026-05-07 | $3.02B derived: sum of 3 quarters · filed 2026-05-07 | $4.02B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $993.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.99B derived: sum of 2 quarters · filed 2026-02-24 | $2.98B derived: sum of 3 quarters · filed 2026-08-06 | $3.99B 10-K · filed 2026-02-24 |
| 2025-09-30 | $995.00M 10-Q · filed 2025-11-07 | $1.99B derived: sum of 2 quarters · filed 2026-08-06 | $3.00B 10-Q · filed 2025-11-07 | $3.97B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $997.00M 10-Q · filed 2026-08-06 | $2.00B 10-Q · filed 2026-08-06 | $2.98B derived: sum of 3 quarters · filed 2026-08-06 | $3.95B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.00B 10-Q · filed 2026-05-07 | $1.98B derived: sum of 2 quarters · filed 2026-05-07 | $2.96B derived: sum of 3 quarters · filed 2026-05-07 | $3.94B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $976.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.95B derived: sum of 2 quarters · filed 2026-02-24 | $2.93B derived: sum of 3 quarters · filed 2026-02-24 | $3.91B 10-K · filed 2026-02-24 |
| 2024-09-30 | $977.00M 10-Q · filed 2025-11-07 | $1.96B derived: sum of 2 quarters · filed 2025-11-07 | $2.94B 10-Q · filed 2025-11-07 | $3.88B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $978.00M 10-Q · filed 2025-08-07 | $1.96B 10-Q · filed 2025-08-07 | $2.91B derived: sum of 3 quarters · filed 2026-02-24 | $3.86B derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $980.00M 10-Q · filed 2025-05-07 | $1.93B derived: sum of 2 quarters · filed 2026-02-24 | $2.88B derived: sum of 3 quarters · filed 2026-02-24 | $3.84B derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $950.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.90B derived: sum of 2 quarters · filed 2026-02-24 | $2.86B derived: sum of 3 quarters · filed 2026-02-24 | $3.81B 10-K · filed 2026-02-24 |
| 2023-09-30 | $953.00M 10-Q · filed 2024-11-12 | $1.91B derived: sum of 2 quarters · filed 2024-11-12 | $2.86B 10-Q · filed 2024-11-12 | $3.79B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $954.00M 10-Q · filed 2024-08-08 | $1.91B 10-Q · filed 2024-08-08 | $2.84B derived: sum of 3 quarters · filed 2025-02-28 | $3.77B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $957.00M 10-Q · filed 2024-05-08 | $1.89B derived: sum of 2 quarters · filed 2025-02-28 | $2.82B derived: sum of 3 quarters · filed 2025-02-28 | $3.75B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $928.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.86B derived: sum of 2 quarters · filed 2025-02-28 | $2.79B derived: sum of 3 quarters · filed 2025-02-28 | $3.73B 10-K · filed 2025-02-28 |
| 2022-09-30 | $933.00M 10-Q · filed 2023-11-07 | $1.86B derived: sum of 2 quarters · filed 2023-11-07 | $2.80B 10-Q · filed 2023-11-07 | $3.70B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $932.00M 10-Q · filed 2023-08-04 | $1.86B 10-Q · filed 2023-08-04 | $2.77B derived: sum of 3 quarters · filed 2024-02-23 | $3.67B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $932.00M 10-Q · filed 2023-05-03 | $1.84B derived: sum of 2 quarters · filed 2024-02-23 | $2.74B derived: sum of 3 quarters · filed 2024-02-23 | $3.64B derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $904.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.81B derived: sum of 2 quarters · filed 2024-02-23 | $2.71B derived: sum of 3 quarters · filed 2024-02-23 | $3.62B 10-K · filed 2024-02-23 |
| 2021-09-30 | $905.00M 10-Q · filed 2022-11-02 | $1.81B derived: sum of 2 quarters · filed 2022-11-02 | $2.71B 10-Q · filed 2022-11-02 | $3.58B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $903.00M 10-Q · filed 2022-08-08 | $1.81B 10-Q · filed 2022-08-08 | $2.67B derived: sum of 3 quarters · filed 2023-02-22 | $3.54B derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $906.00M 10-Q · filed 2022-05-04 | $1.77B derived: sum of 2 quarters · filed 2023-02-22 | $2.64B derived: sum of 3 quarters · filed 2023-02-22 | $3.50B derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $865.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.73B derived: sum of 2 quarters · filed 2023-02-22 | $2.60B derived: sum of 3 quarters · filed 2023-02-22 | $3.46B 10-K · filed 2023-02-22 |
| 2020-09-30 | $866.00M 10-Q · filed 2021-11-03 | $1.73B derived: sum of 2 quarters · filed 2021-11-03 | $2.60B 10-Q · filed 2021-11-03 | $3.41B derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $866.00M 10-Q · filed 2021-08-05 | $1.73B 10-Q · filed 2021-08-05 | $2.54B derived: sum of 3 quarters · filed 2022-02-23 | $3.35B derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $867.00M 10-Q · filed 2021-05-06 | $1.68B derived: sum of 2 quarters · filed 2022-02-23 | $2.48B derived: sum of 3 quarters · filed 2022-02-23 | $3.29B derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $808.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.61B derived: sum of 2 quarters · filed 2022-02-23 | $2.42B derived: sum of 3 quarters · filed 2022-02-23 | $3.24B 10-K · filed 2022-02-23 |
| 2019-09-30 | $807.00M 10-Q · filed 2020-11-04 | $1.62B derived: sum of 2 quarters · filed 2020-11-04 | $2.43B 10-Q · filed 2020-11-04 | $3.17B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $810.00M 10-Q · filed 2020-08-06 | $1.62B 10-Q · filed 2020-08-06 | $2.37B derived: sum of 3 quarters · filed 2021-02-25 | $3.11B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $814.00M 10-Q · filed 2020-05-06 | $1.55B derived: sum of 2 quarters · filed 2021-02-25 | $2.30B derived: sum of 3 quarters · filed 2021-02-25 | $3.05B derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $741.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.49B derived: sum of 2 quarters · filed 2021-02-25 | $2.23B derived: sum of 3 quarters · filed 2021-02-25 | $2.99B 10-K · filed 2021-02-25 |
| 2018-09-30 | $746.00M 10-Q · filed 2019-11-05 | $1.49B derived: sum of 2 quarters · filed 2019-11-05 | $2.25B 10-Q · filed 2019-11-05 | $2.93B derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $747.00M 10-Q · filed 2019-08-06 | $1.50B 10-Q · filed 2019-08-06 | $2.19B derived: sum of 3 quarters · filed 2020-02-25 | $2.87B derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $752.00M 10-Q · filed 2019-05-08 | $1.44B derived: sum of 2 quarters · filed 2020-02-25 | $2.12B derived: sum of 3 quarters · filed 2020-02-25 | $2.81B derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $687.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.37B derived: sum of 2 quarters · filed 2020-02-25 | $2.06B derived: sum of 3 quarters · filed 2020-02-25 | $2.74B 10-K · filed 2020-02-25 |
| 2017-09-30 | $685.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.37B derived: sum of 2 quarters · filed 2017-11-07 | $2.06B 10-Q · filed 2017-11-07 | $2.68B derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $685.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.37B 10-Q · filed 2017-08-07 | $1.99B derived: sum of 3 quarters · filed 2019-02-26 | $2.62B derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $685.00M 10-Q · filed 2017-05-10 | $1.31B derived: sum of 2 quarters · filed 2019-02-26 | $1.93B derived: sum of 3 quarters · filed 2019-02-26 | $2.56B derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $622.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.25B derived: sum of 2 quarters · filed 2019-02-26 | $1.88B derived: sum of 3 quarters · filed 2019-02-26 | $2.46B 10-K · filed 2019-02-26 |
| 2016-09-30 | $625.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.26B derived: sum of 2 quarters · filed 2016-11-07 | $1.84B 10-Q · filed 2016-11-07 | $2.46B derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $631.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.22B 10-Q · filed 2016-08-05 | $1.84B derived: sum of 3 quarters · filed 2018-02-27 | $2.47B derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $587.00M 10-Q · filed 2016-05-06 | $1.21B derived: sum of 2 quarters · filed 2018-02-27 | $1.84B derived: sum of 3 quarters · filed 2018-02-27 | $2.48B derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $620.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.25B derived: sum of 2 quarters · filed 2018-02-27 | $1.89B derived: sum of 3 quarters · filed 2018-02-27 | $1.89B 10-K · filed 2018-02-27 |
| 2015-09-30 | $631.00M 10-Q · filed 2015-11-04 | $1.27B derived: sum of 2 quarters · filed 2015-11-04 | $1.27B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $639.00M 10-Q · filed 2015-11-04 | $639.00M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |